IronBridge Capital Management’s Abiomed Inc ABMD Stock Holding History

IronBridge Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$6.16M	Buy	49,216 +14,350	+41%	+$1.66M	0.37%	93
2016 Q4	$3.93M	Sell	34,866 -240	-0.7%	-$27.8K	0.18%	127
2016 Q3	$4.51M	Buy	35,106 +1,406	+4%	+$168K	0.21%	121
2016 Q2	$3.68M	Sell	33,700 -830	-2%	-$82.6K	0.16%	137
2016 Q1	$3.27M	Buy	34,530 +2,360	+7%	+$199K	0.13%	145
2015 Q4	$2.9M	Buy	+32,170	New	+$2.73M	0.11%	142

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

IronBridge Capital Management's ABMD Position: Q1 2017 in Review

IronBridge Capital Management increased its Abiomed Inc (ABMD) stake by 41% in Q1 2017, buying an estimated $1.66M and bringing the position to 49,216 shares worth $6.16M. The position accounts for 0.37% of the portfolio, ranked #93.

IronBridge Capital Management first reported a position in ABMD in Q4 2015 and has held it in 6 quarters since. 287 funds tracked by Wall St. Rank hold ABMD as of Q1 2017.

IronBridge Capital Management held 49,216 shares of Abiomed Inc worth $6.16M as of Q1 2017.
IronBridge Capital Management bought 14,350 Abiomed Inc shares in Q1 2017, an estimated $1.66M.
Abiomed Inc made up 0.37% of IronBridge Capital Management's portfolio in Q1 2017, its #93 holding.
IronBridge Capital Management first reported a position in Abiomed Inc in Q4 2015 and has held it in 6 quarters since.
287 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.